Evidence map›Paper›PMID 39448851›Full record

ArticleEye (London, England)2025

The no-retina-touch technique: vitrectomy and platelet-rich plasma in the treatment of lamellar macular hole. New insights into pathogenesis.

Federico Ricardi, Francesco Gelormini, Guglielmo Parisi, Veronica Vallino, Enrico Borrelli, Paola Marolo, Sergio D'Antico, Marika Salafia, Michele Reibaldi

Abstract read
In one paragraph

Article in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Current Topics in OCT Applications in Vitreoretinal Surgery.Bioengineering (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Federico RicardiDepartment of Ophthalmology, University of Turin, Turin, Italy.ORCID 0000-0002-9004-8547
Francesco GelorminiDepartment of Ophthalmology, University of Turin, Turin, Italy. francesco.gelormini@hotmail.com.ORCID 0000-0002-4640-4559
Guglielmo ParisiDepartment of Ophthalmology, University of Turin, Turin, Italy.ORCID 0000-0003-0795-618X
Veronica VallinoDepartment of Ophthalmology, University of Turin, Turin, Italy.
Enrico BorrelliDepartment of Ophthalmology, University of Turin, Turin, Italy.ORCID 0000-0003-2815-5031
Paola MaroloDepartment of Ophthalmology, University of Turin, Turin, Italy.
Sergio D'AnticoBlood Bank, "Città della Salute e della Scienza" Hospital, Turin, Italy.
Marika SalafiaBlood Bank, "Città della Salute e della Scienza" Hospital, Turin, Italy.
Michele ReibaldiDepartment of Ophthalmology, University of Turin, Turin, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo explore the use of autologous platelet-rich plasma (PRP) as a potential therapeutic adjuvant strategy for treating degenerative lamellar macular holes (LMHs).

designA prospective interventional case series.

methodsSeven consecutive patients (8 eyes) with a diagnosis of LMH underwent a pars-plana vitrectomy with PRP injection under air tamponade. Anatomical results based on spectral domain optical coherence tomography (SD-OCT) and functional results, in terms of best corrected visual acuity (BCVA) and reading performance, were analyzed.

resultsAt 12 months postoperatively, 7 out of 8 eyes (88%) presented a complete closure of the LMH. The ellipsoid zone (EZ) was restored in 3 eyes (37.5%). The mean (±SD) postoperative BCVA was 0.39 (±0.56) LogMAR, resulting in a statistically significant visual acuity improvement (p = 0.007). The mean (±SD) maximum reading speed (MaxRS) improved to 133.48 (±41.47) wpm, with a significant increase compared to the baseline (p = 0.029). The mean (±SD) reading acuity score (RA score) resulted in 0.44 (±0.04) LogRAD, with an improvement in reading acuity that did not reach statistical significance (p = 0.129).

conclusionsThe utilization of the PRP technique with a no-retina-touch approach safeguards the delicate retinal tissues, minimizing the possibility of iatrogenic trauma or post-operative complications, while maintaining a high rate of efficacy in enabling the improvement of the foveal defect in lamellar macular holes.

Indexed as

Platelet-Rich PlasmaRetinal PerforationsVitrectomyAgedAged, 80 and overEndotamponadeFemaleHumansMaleMiddle AgedProspective StudiesTomography, Optical CoherenceTreatment OutcomeVisual Acuity

Identifiers

PMID39448851
PMCPMC11751382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.